![DSM-Firmenich AG Website](https://cdn.finchat.io/410412.png)
DSM-Firmenich AG
ENXTAM-DSFIR
Company Overview
DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.
Name
DSM-Firmenich AG
CEO
Mr. Dimitri de Vreeze
Website
www.dsm-firmenich.com
Sector
Chemicals
Year Founded
1902
Profile
Market Cap
€31.57B
EV
€35.23B
Shares Out
265.28M
Revenue
€12.46B
Employees
27,926
Margins
Gross
27.19%
EBITDA
8.52%
Operating
-0.26%
Pre-Tax
-0.78%
Net
-1.51%
FCF
7.08%
Returns (5Yr Avg)
ROA
7.21%
ROTA
24.59%
ROE
12.2%
ROCE
3.94%
ROIC
3.52%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
€126.78
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
€1,086M
Net Debt
€3,496M
Debt/Equity
0.21
EBIT/Interest
-0.3
Growth (CAGR)
Rev 3Yr
18.12%
Rev 5Yr
7.94%
Rev 10Yr
4.75%
Dil EPS 3Yr
-53.69%
Dil EPS 5Yr
-31.57%
Dil EPS 10Yr
-4.22%
Rev Fwd 2Yr
3.66%
EBITDA Fwd 2Yr
13.76%
EPS Fwd 2Yr
34.85%
EPS LT Growth Est
40.77%
Dividends
Yield
—
Payout
-33.05%
DPS
€0.93
DPS Growth 3Yr
-27.03%
DPS Growth 5Yr
-16.52%
DPS Growth 10Yr
-5.55%
DPS Growth Fwd 2Yr
1.08%